WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 15-July-2016 (15-July-2016)
Next overall update Fall 2016
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'7201 Infant (under 12 months) mortality rate: 112
GDP / capita (US$): 7'5821 Child (under 5 years) mortality rate: 122

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 4'000  4'035  4'083  4'139  4'196  4'744  5'460  5'073 
Births 54  55  56  57  58  57  91  95 
Surviving infants 53  54  56  57  58  55  87  90 
Pop. less than 5 years 275  276  278  278  274  276  458  434 
Pop. less than 15 years 693  694  700  707  714  1'040  1'344  1'308 
Female 15-49 years 997  1'016  1'040  1'067  1'096  1'236  1'348  1'325 

Number of reported cases

(Click for retrospective incidence data for Georgia)
Diphtheria
ChartChart
  28 
Japanese encephalitis
ChartChart
 
Measles
ChartChart ChartChart
  431  3'188  7'872  31  64  50 
Mumps
ChartChart
  50  55  52  50  44  2'646 
Pertussis
ChartChart
  176  94  115  346  33  84 
Polio*
ChartChart
 
Rubella
ChartChart
  100  149  224  75  64  428 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Georgia)
Vaccine year result method % card seen                                                
BCG 1998  92  EPI   86  96  96  95  95  96  95 
DTP1 1998  87  EPI   86  97  99*  99*  94  92  99 
DTP3 1998  80  EPI   86  94  91  96  92  94  98 
DTP4          87  90 
IPV1          10 
HepB_BD          93  95  80  92  93 
HepB3          94  91  96  92  89  55 
Hib3          87  91  96  92  94 
JapEnc         
MCV1          96  92  97  93  91  97 
MCV2          91  87  89  79  77 
PCV1          99*  10 
PCV3          16 
Pol3 1998  80  EPI   86  91  91  94  93  88  98 
Rota1          80  77  74 
RotaC          72  69  56 
Rubella1          96  92  97  93  94 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2017

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Georgia)
BCG
ChartChart
  96  96  95  95  96  95 
DTP1
ChartChart
  97  99  99  94  98  89 
DTP3
ChartChart
  94  91  96  92  94  80 
HepB3
ChartChart
  94  91  96  92  89  55 
HepB_BD
ChartChart
  93  95  80  92  93 
Hib3
ChartChart
  87  91  96  92  94 
MCV1
ChartChart
  96  92  97  93  91  73 
MCV2
ChartChart
  91  87  89  79  77 
PCV3
ChartChart
  16 
Pol3
ChartChart
  91  91  94  93  88  81 
RCV1
ChartChart
  96  92  97  93  91 
RotaC
ChartChart
  72  69  41 

Number of districts in the country 65  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 63
From 80 to 89% 26
From 50 to 79% 9
Less than 50% 2
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 0-5 days; Yes
DT 5 years; Yes
DTaPHepBIPV 2, 3, 4 months; Yes
DTwP 18 months; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepB_Pediatric birth; Yes
Influenza_Adult Yes For adults with chronic illness, health care workers and other risk groups
Influenza_Pediatric Yes and chronic illness
MMR 12 months; 5 years; Yes
OPV 2, 3, 4, 18 months; 5 years; Yes
Pneumo_conj 2, 3, 12 months; Yes
Rotavirus 2, 3 months; Yes
Td 14 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2012-2016  2010/2015  2007-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 65  65  65  65  65  63  65 

System performance

Total Nº districts in country number 65  65  65  65  65  65  65 
Nº districts with DTP3 coverage >=80% number 58  61  61  59  62  55  55 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  94  94  91  95  85  85 
Nº districts with measles (MCV1) coverage >=95% number 46  32  41  31  35  43 
% of districts with MCV1 coverage >=95% From 0 to 100% 71  49  63  48  54  66 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes  Yes   
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 93  77  49  38  100  64  97 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  No  No  No  No   

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.